BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15326273)

  • 1. Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies.
    Petereit HF; Perniok A
    Neurology; 2004 Aug; 63(4):762-3; author reply 762-3. PubMed ID: 15326273
    [No Abstract]   [Full Text] [Related]  

  • 2. [Primary Sjögren's syndrome revealing cerebellar syndrome].
    Meriglier E; Debouverie O; Walter-Lepage A; Brigaud A; Beuvon C; Luca L
    Rev Neurol (Paris); 2015 Sep; 171(8-9):674-6. PubMed ID: 25912281
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-Ro and anti-La autoantibody profiling in Norwegian patients with primary Sjögren's syndrome using luciferase immunoprecipitation systems (LIPS).
    Volchenkov R; Jonsson R; Appel S
    Scand J Rheumatol; 2012 Aug; 41(4):314-5. PubMed ID: 22804348
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies.
    Hummers LK; Krishnan C; Casciola-Rosen L; Rosen A; Morris S; Mahoney JA; Kerr DA; Wigley FM
    Neurology; 2004 Jan; 62(1):147-9. PubMed ID: 14718721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-SS-A/Ro, anti-SS-B/La antibody].
    Okano T; Satoh M; Akizuki M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():541-4. PubMed ID: 20942124
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
    Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
    Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sjogren's syndrome.
    Soliotis FC; Moutsopoulos HM
    Autoimmunity; 2004 Jun; 37(4):305-7. PubMed ID: 15518047
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-Ro/SSA-associated annular erythema in childhood.
    Miyagawa S; Iida T; Fukumoto T; Matsunaga T; Yoshioka A; Shirai T
    Br J Dermatol; 1995 Nov; 133(5):779-82. PubMed ID: 8555033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late development of anti-La/SS-B antibodies in a patient with Sjogren's syndrome and high titer anti-Ro/SS-A antibodies.
    Satoh M; Hamilton KJ; Langdon JJ; Akizuki M; Yamagata H; Nakayama S; Reeves WH; Homma M
    Lupus; 1996 Aug; 5(4):337-9. PubMed ID: 8869909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to Ro and La.
    Reichlin M
    Ann Med Interne (Paris); 1998 Feb; 149(1):34-41. PubMed ID: 11490515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic value of antiperinuclear factor in primary Sjogren's syndrome].
    Varshavskaia AA; Shilkina NP; Baranov AA; Makarushin AA
    Klin Lab Diagn; 2000 Jan; (1):35-7. PubMed ID: 10878900
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neuromyelitis optica spectrum disorders as initial presentation of Sjögren's syndrome: A case report].
    Alva Díaz C; Andamayo Villalba L; Mori N; Ventura Chilón JJ; Romero R
    Medwave; 2016 Feb; 16(1):e6388. PubMed ID: 26938585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of antibody assays for detection of autoantibodies to Ro 52, Ro 60 and La associated with primary Sjögren's syndrome.
    Trier NH; Nielsen IØ; Friis T; Houen G; Theander E
    J Immunol Methods; 2016 Jun; 433():44-50. PubMed ID: 26956184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune autonomic ganglionopathy with Sjögren's syndrome: significance of ganglionic acetylcholine receptor antibody and therapeutic approach.
    Kondo T; Inoue H; Usui T; Mimori T; Tomimoto H; Vernino S; Takahashi R
    Auton Neurosci; 2009 Mar; 146(1-2):33-5. PubMed ID: 19097826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of Sjögren's syndrome with acute transverse myelitis and polyneuropathy in a patient free of sicca symptoms.
    Tristano AG
    Clin Rheumatol; 2006 Feb; 25(1):113-4. PubMed ID: 15980937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.
    Lawind MF; Alyasky A; Elwan NM; Mourad H; Al-Bendary A
    Egypt J Immunol; 2004; 11(1):75-81. PubMed ID: 15724389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral facial paralysis as a rare neurological manifestation of primary Sjögren's syndrome: case-based review.
    Wei Z; Jiaying S; Junhong G
    Rheumatol Int; 2019 Sep; 39(9):1651-1654. PubMed ID: 31175417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of anti-60000 SSA antibody and anti-52000 SSA antibody with systemic lupus erythematosus and Sjögren's syndrome].
    Zhang FC; Liu L; Xu D
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):7-10. PubMed ID: 17403303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun.
    Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
    Lupus; 2007; 16(1):10-7. PubMed ID: 17283579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
    Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
    Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.